Atika Capital Management’s Astera Labs ALAB Stock Holding History

Atika Capital Management’s Portfolio ALAB Stock Details ALAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-900	Closed	-$4.72M	–	116
2024 Q3	$4.72M	Buy	+900	New	+$42.2K	0.48%	62

Other funds holding ALAB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Atreides Management Boston, Massachusetts $14.3B AUM 116.01% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Atika Capital Management's ALAB Position: Q1 2025 in Review

Atika Capital Management sold out of Astera Labs (ALAB) in Q1 2025, closing a stake of 24,300 shares — an estimated $3.22M sold.

Atika Capital Management first reported a position in ALAB in Q4 2024 and held it in 1 quarter. The position peaked at $3.22M in Q4 2024. 391 funds tracked by Wall St. Rank hold ALAB as of Q1 2025.

Atika Capital Management reported no remaining Astera Labs position as of Q1 2025 after selling out during the quarter.
Atika Capital Management sold 24,300 Astera Labs shares in Q1 2025, an estimated $3.22M.
Atika Capital Management first reported a position in Astera Labs in Q4 2024 and held it in 1 quarter.
Atika Capital Management's Astera Labs position peaked at $3.22M in Q4 2024.
391 funds tracked by Wall St. Rank held Astera Labs as of Q1 2025.

Based on Atika Capital Management's 13F filing for Q1 2025, filed 14 May 2025.